Substance Abuse
Overview
Substance Abuse is a peer-reviewed journal that focuses on the study and understanding of substance abuse and addiction. It covers a wide range of topics, including prevention, treatment, epidemiology, neuroscience, and policy. With a multidisciplinary approach, the journal provides valuable insights and evidence-based research to professionals and researchers in the field of substance abuse.
Details
Details
Abbr.
Subst Abus
Publisher
Sage Publications
Start
1980
End
2023
Frequency
Quarterly
p-ISSN
0889-7077
e-ISSN
1547-0164
Country
United States
Language
English
Specialties
Psychiatry
Medical Education
Medical Education
Metrics
Metrics
h-index / Ranks: 6339
58
SJR / Ranks: 2538
1282
CiteScore / Ranks: 6878
3.90
JIF / Ranks: 2766
3.5
Recent Articles
1.
Salvador J, Myers O, Bhatt S, Jacobsohn V, Lindsey L, Alkhafaji R, et al.
Subst Abus
. 2023 Oct;
44(4):282-291.
PMID: 37902036
Background: Lack of access to buprenorphine to treat Opioid Use Disorder is profound in rural areas where over half of small and remote rural counties have no buprenorphine prescriber. To...
2.
Bosley H, Pena J, Penn A, Sorensen J, Tierney M, Flentje A
Subst Abus
. 2023 Oct;
44(4):337-347.
PMID: 37902034
Background: Rates of cannabis use are increasing in the United States, likely as a result of changes in societal attitudes and expanding legalization. Although many patients report wanting to discuss...
3.
Jarrett J, Bratberg J, Burns A, Cochran G, DiPaula B, Dopp A, et al.
Subst Abus
. 2023 Oct;
44(4):264-276.
PMID: 37902032
In the last decade, the U.S. opioid overdose crisis has magnified, particularly since the introduction of synthetic opioids, including fentanyl. Despite the benefits of medications for opioid use disorder (MOUD),...
4.
Cook R, Jaworski E, Hoffman K, Waddell E, Myers R, Korthuis P, et al.
Subst Abus
. 2023 Oct;
44(4):301-312.
PMID: 37842910
Background: People living with HIV and opioid use disorder (OUD) are disproportionally affected by adverse socio-structural exposures negatively affecting health, which have shown inconsistent associations with uptake of medications for...
5.
Sheffer C, Shevorykin A, Freitas-Lemos R, Vantucci D, Carl E, Bensch L, et al.
Subst Abus
. 2023 Oct;
44(4):313-322.
PMID: 37842906
Background: Tobacco-related disparities are a leading contributor to health inequities among marginalized communities. Lack of support from health professionals is one of the most cited barriers to tobacco cessation reported...
6.
Percy A, Kelley A, Valentino N, Butz A, Baylis J, Suo Y, et al.
Subst Abus
. 2023 Oct;
44(4):330-336.
PMID: 37840212
Background: Clinical pharmacist practitioners (CPPs) play an increasingly important role in interdisciplinary care for patients with substance use disorders (SUDs). However, CPPs' scope of practice varies substantially across clinics and...
7.
Ly S, Fitzpatrick A, Canfield J, Powis A, So-Armah K, Hurstak E
Subst Abus
. 2023 Oct;
44(4):277-281.
PMID: 37830542
Developing a diverse Addiction Medicine (AM) workforce will improve medical and public health responses to the increasing health risks created by substance use disorders (SUDs). A workforce that embraces diversity,...
8.
Li Y, Barr K, Trafton J, Oliva E, Garrido M, Frakt A, et al.
Subst Abus
. 2023 Oct;
44(4):292-300.
PMID: 37830514
Background: Although long-term opioid therapy (LTOT) has its own risks, opioid discontinuation could pose harm for high-risk Veterans Health Administration (VHA) patients receiving LTOT. There is limited information on the...
9.
Ravi A, Vittinghoff E, Wu A, Suen L, Coffin P, Hsue P, et al.
Subst Abus
. 2023 Oct;
44(4):323-329.
PMID: 37830512
Background: While substance use is known to influence cardiovascular health, most prior studies only consider one substance at a time. We examined associations between the concurrent use of multiple substances...
10.
Lagisetty P, Kertesz S
Subst Abus
. 2023 Sep;
44(3):112-114.
PMID: 37737138
In 2022, the CDC revised its and encourage clinicians to weight the risks versus harms of continued therapy and empathetically engage patients in patient-centered discussions around continued therapy while avoiding...